These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 25812294)

  • 21. Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.
    Räber L; Windecker S
    Circulation; 2011 Apr; 123(16):1709-12. PubMed ID: 21482962
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of drug-eluting stent restenosis.
    Ishikawa K; Aoyama Y; Hirayama H
    J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common polymorphism +45T/G in adiponectin gene as potential modulator of in-stent restenosis development.
    Bienertova-Vasku J; Bienert P; Hlinomaz O; Vasku A
    Int J Cardiol; 2010 Nov; 145(2):351. PubMed ID: 20045207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful balloon angioplasty of in-stent restenosis of left internal mammary artery.
    Chandrasekar B; deGuise P; Doucet S
    J Invasive Cardiol; 1999 Jul; 11(7):447-9. PubMed ID: 10745571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute coronary syndrome is a common clinical manifestation of in-stent restenosis].
    Zhang YZ; Mao JM; Guo LJ; Zhang FC; Niu J; Li HY
    Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):470-2. PubMed ID: 12921605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of restenosis after coronary stenting, problem soon resolved].
    Kivelä A; Hartikainen J
    Duodecim; 2005; 121(11):1227-36. PubMed ID: 15999982
    [No Abstract]   [Full Text] [Related]  

  • 27. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammation inhibitory effects of sirolimus and paclitaxel-eluting stents on interleukin-1β-induced coronary artery in-stent restenosis in pigs.
    Zhou XC; Huang RC; Zhang B; Yin D; Liang B; Wang SP; Guan QG; Sun XZ; Miao ZL; He XZ; Han FT; Cheng Y; Zhang L; Zeng DY
    Chin Med J (Engl); 2010 Sep; 123(17):2405-9. PubMed ID: 21034557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case for live case demonstrations.
    King SB
    JACC Cardiovasc Interv; 2013 Aug; 6(8):895-6. PubMed ID: 23968709
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of restenosis of central venous stricture after percutaneous transluminal angioplasty and endovascular stenting by brachytherapy.
    Wong FK; Kwok PC; Ngan RK; Wong RK; Wong KW; Chan S; Chau KF; Li CS
    Kidney Int; 1999 Feb; 55(2):742-3. PubMed ID: 9987101
    [No Abstract]   [Full Text] [Related]  

  • 31. Left main coronary stent positioning using rapid transcoronary pacing.
    O'Sullivan CJ; Meier B
    J Invasive Cardiol; 2013 Jan; 25(1):E4-7. PubMed ID: 23293185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 33. Tissue shearing with distal translocation complicating cutting balloon angioplasty during treatment of in-stent restenosis.
    Smith CH; Erwin MB; Deliargyris EN
    J Invasive Cardiol; 2005 Jan; 17(1):40-1. PubMed ID: 15640539
    [No Abstract]   [Full Text] [Related]  

  • 34. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
    Nishimura M; Takahashi H
    Rinsho Byori; 2011 Aug; 59(8):795-800. PubMed ID: 21942090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis.
    Fasseas P; Orford JL; Lennon R; O'Neill J; Denktas AE; Panetta CJ; Berger PB; Holmes DR
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):152-7. PubMed ID: 15390249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comment to article Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis].
    Bryniarski L
    Kardiol Pol; 2010 Jun; 68(6):646-7. PubMed ID: 20806193
    [No Abstract]   [Full Text] [Related]  

  • 37. Multislice CT for assessing in-stent dimensions after left main coronary artery stenting: a comparison with three dimensional intravascular ultrasound.
    Roura G; Gomez-Lara J; Ferreiro JL; Gomez-Hospital JA; Romaguera R; Teruel LM; Carreño E; Esplugas E; Alfonso F; Cequier A
    Heart; 2013 Aug; 99(15):1106-12. PubMed ID: 23723447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel approach to the management of occlusive in-stent restenosis (ISR).
    Wilson WM; Walsh S; Hanratty C; Strange J; Hill J; Sapontis J; Spratt JC
    EuroIntervention; 2014 Mar; 9(11):1285-93. PubMed ID: 24650770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.